Public Health

Will US-EU Tariffs Raise Costs for Drugs Like Ozempic?
Clinical & Pharma Will US-EU Tariffs Raise Costs for Drugs Like Ozempic?

The landscape of American healthcare is facing a significant shakeup with the recent announcement of a US-EU trade agreement that introduces a 15 percent tariff on branded pharmaceuticals imported from Europe, raising alarms for millions of patients who depend on critical medications. This policy,

What Drives EBV Infection Trends in Southwestern Saudi Arabia?
Clinical & Pharma What Drives EBV Infection Trends in Southwestern Saudi Arabia?

In Southwestern Saudi Arabia, a region characterized by unique demographic and environmental traits, the Epstein-Barr Virus (EBV) presents a significant public health challenge with profound implications for both mild and severe health conditions. Known worldwide for its links to diseases ranging

Why Did CDC Silence Worsen Texas Measles Outbreak in 2023?
Clinical & Pharma Why Did CDC Silence Worsen Texas Measles Outbreak in 2023?

Introduction: A Preventable Tragedy Unfolds in Texas In early 2023, Texas became the focal point of the most severe measles outbreak in the United States in over three decades, revealing critical vulnerabilities in the nation’s public health framework. This crisis, which unfolded during the early

Debunking False Claims on Groundbreaking RSV Therapies
Clinical & Pharma Debunking False Claims on Groundbreaking RSV Therapies

In a world where medical advancements are often met with both hope and skepticism, the battle against Respiratory Syncytial Virus (RSV) stands as a testament to human ingenuity, yet it is not without its controversies. RSV, a pervasive respiratory illness, has long been a leading cause of

NIH Funding Drives Jobs and Biotech Growth Across US
Clinical & Pharma NIH Funding Drives Jobs and Biotech Growth Across US

The National Institutes of Health (NIH) serves as a vital force in shaping not only the future of medical research but also the economic landscape of the United States, channeling billions of dollars into initiatives that advance health outcomes while simultaneously spurring job creation and

How Is Elizabethkingia Impacting the MENA Region's Health?
Clinical & Pharma How Is Elizabethkingia Impacting the MENA Region's Health?

In the intricate tapestry of public health challenges facing the Middle East and North Africa (MENA) region, a subtle yet increasingly alarming threat has surfaced in the form of Elizabethkingia, a genus of Gram-negative bacteria known for causing severe infections in vulnerable populations. Often

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later